ArticleCancer medicine2023

Rh-endostatin plus camrelizumab and chemotherapy in first-line treatment of advanced non-small cell lung cancer: A multicenter retrospective study.

Xingxiang Pu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.